• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非小细胞肺癌患者中FAM107A表达降低

Decreased FAM107A Expression in Patients with Non-small Cell Lung Cancer.

作者信息

Pastuszak-Lewandoska D, Czarnecka K H, Migdalska-Sęk M, Nawrot E, Domańska D, Kiszałkiewicz J, Kordiak J, Antczak A, Górski P, Brzeziańska-Lasota E

机构信息

Department of Molecular Bases of Medicine, Medical University of Lodz, 251 Pomorska St., 92-213, Lodz, Poland.

出版信息

Adv Exp Med Biol. 2015;852:39-48. doi: 10.1007/5584_2014_109.

DOI:10.1007/5584_2014_109
PMID:25753555
Abstract

Lung cancer is the leading cause of cancer-related death in the world. Early detection, based on molecular markers, could decrease mortality from this disease. Tumor development is often associated with inactivation or loss of tumor suppressor genes (TSGs). The aim of the present study was to analyze the expression level of FAM107A gene, a TSG located in 3p21.1, in lung cancer tumors and in tumor adjacent normal lung samples. Promoter methylation status of FAM107A was evaluated as the potential mechanism of its epigenetic silencing. The relationship between gene mRNA expression and tumor staging, metastasis status, and non-small cell lung cancer (NSCLC) histopathological subtypes in 60 patients was analyzed. Total RNA was isolated from tissue samples and gene expression was assessed in qPCR assay. Gene promoter methylation status was evaluated in MSP reactions, using bisulfite converted DNA and two pairs of primers: methylated and unmethylated. We found that the expression of the gene was dramatically decreased in all NSCLC samples and was significantly lower than in tumor adjacent normal lung tissue. Promoter methylation of FAM107A gene was confirmed only in the minority of NSCLCs. The results highlight the importance of FAM107A in lung carcinogenesis, although indicate other than promoter hypermethylation mechanism of the gene decreased expression.

摘要

肺癌是全球癌症相关死亡的主要原因。基于分子标志物的早期检测可降低该疾病的死亡率。肿瘤发展通常与肿瘤抑制基因(TSG)的失活或缺失有关。本研究的目的是分析位于3p21.1的TSG基因FAM107A在肺癌肿瘤组织及肿瘤旁正常肺组织样本中的表达水平。评估FAM107A的启动子甲基化状态作为其表观遗传沉默的潜在机制。分析了60例患者中基因mRNA表达与肿瘤分期、转移状态及非小细胞肺癌(NSCLC)组织病理学亚型之间的关系。从组织样本中提取总RNA,并通过qPCR检测评估基因表达。使用亚硫酸氢盐转化的DNA和两对引物(甲基化和未甲基化引物)在MSP反应中评估基因启动子甲基化状态。我们发现,该基因在所有NSCLC样本中的表达均显著降低,且明显低于肿瘤旁正常肺组织。仅在少数NSCLC中证实了FAM107A基因的启动子甲基化。结果突出了FAM107A在肺癌发生中的重要性,尽管表明该基因表达降低的机制并非启动子高甲基化。

相似文献

1
Decreased FAM107A Expression in Patients with Non-small Cell Lung Cancer.非小细胞肺癌患者中FAM107A表达降低
Adv Exp Med Biol. 2015;852:39-48. doi: 10.1007/5584_2014_109.
2
Quantitative analysis of mRNA expression levels and DNA methylation profiles of three neighboring genes: FUS1, NPRL2/G21 and RASSF1A in non-small cell lung cancer patients.非小细胞肺癌患者中三个相邻基因FUS1、NPRL2/G21和RASSF1A的mRNA表达水平及DNA甲基化谱的定量分析。
Respir Res. 2015 Jun 26;16(1):76. doi: 10.1186/s12931-015-0230-6.
3
[Promoter methylation of ASPP1 and ASPP2 genes in non-small cell lung cancers].非小细胞肺癌中ASPP1和ASPP2基因的启动子甲基化
Zhonghua Bing Li Xue Za Zhi. 2011 Aug;40(8):532-6.
4
Allelic loss on chromosome 3p21.3 and promoter hypermethylation of semaphorin 3B in non-small cell lung cancer.非小细胞肺癌中3号染色体p21.3区域的等位基因缺失及信号素3B的启动子高甲基化
Cancer Res. 2003 Jun 15;63(12):3352-5.
5
FHIT promoter methylation status, low protein and high mRNA levels in patients with non-small cell lung cancer.非小细胞肺癌患者中FHIT启动子甲基化状态、低蛋白水平和高mRNA水平
Int J Oncol. 2016 Sep;49(3):1175-84. doi: 10.3892/ijo.2016.3610. Epub 2016 Jul 6.
6
Methylation screening of the TGFBI promoter in human lung and prostate cancer by methylation-specific PCR.通过甲基化特异性PCR对人肺癌和前列腺癌中TGFBI启动子进行甲基化筛查。
BMC Cancer. 2008 Oct 3;8:284. doi: 10.1186/1471-2407-8-284.
7
Frequent epigenetic inactivation of deleted in lung and esophageal cancer 1 gene by promoter methylation in non-small-cell lung cancer.非小细胞肺癌中因启动子甲基化导致肺及食管发育不全相关基因 1 频繁的表观遗传失活。
Clin Lung Cancer. 2010 Jul 1;11(4):264-70. doi: 10.3816/CLC.2010.n.034.
8
Promoter methylation-mediated silencing of β-catenin enhances invasiveness of non-small cell lung cancer and predicts adverse prognosis.β-连环蛋白启动子甲基化介导的沉默增强非小细胞肺癌的侵袭性并预示不良预后。
PLoS One. 2014 Nov 14;9(11):e112258. doi: 10.1371/journal.pone.0112258. eCollection 2014.
9
p16(INK4A) Hypermethylation detected by fluorescent methylation-specific PCR in plasmas from non-small cell lung cancer.通过荧光甲基化特异性PCR在非小细胞肺癌患者血浆中检测到p16(INK4A)高甲基化。
Clin Cancer Res. 2002 Dec;8(12):3782-7.
10
Adenomatous polyposis coli gene promoter hypermethylation in non-small cell lung cancer is associated with survival.非小细胞肺癌中腺瘤性息肉病结肠基因启动子高甲基化与生存相关。
Oncogene. 2001 Jun 14;20(27):3528-32. doi: 10.1038/sj.onc.1204455.

引用本文的文献

1
Construction of a risk model associated with tryptophan metabolism and identification of related molecular subtypes in laryngeal squamous cell carcinoma.构建与色氨酸代谢相关的风险模型并鉴定喉鳞状细胞癌中的相关分子亚型
Front Genet. 2025 Mar 24;16:1530334. doi: 10.3389/fgene.2025.1530334. eCollection 2025.
2
Transcriptomics of mussel transmissible cancer MtrBTN2 suggests accumulation of multiple cancer traits and oncogenic pathways shared among bilaterians.贻贝传染性癌症 MtrBTN2 的转录组学研究表明,多种癌症特征和两侧动物共有的致癌途径在贻贝中积累。
Open Biol. 2023 Oct;13(10):230259. doi: 10.1098/rsob.230259. Epub 2023 Oct 11.
3
Integrated bioinformatics analyses identifying key transcriptomes correlated with prognosis and immune infiltrations in lung squamous cell carcinoma.
综合生物信息学分析确定与肺鳞状细胞癌预后和免疫浸润相关的关键转录组。
Saudi J Biol Sci. 2023 Apr;30(4):103596. doi: 10.1016/j.sjbs.2023.103596. Epub 2023 Feb 11.
4
A feature selection-based framework to identify biomarkers for cancer diagnosis: A focus on lung adenocarcinoma.基于特征选择的癌症诊断生物标志物识别框架:以肺腺癌为例。
PLoS One. 2022 Sep 6;17(9):e0269126. doi: 10.1371/journal.pone.0269126. eCollection 2022.
5
DRR1 promotes neuroblastoma cell differentiation by regulating CREB expression.DRR1 通过调节 CREB 表达促进神经母细胞瘤细胞分化。
Pediatr Res. 2023 Mar;93(4):852-861. doi: 10.1038/s41390-022-02192-8. Epub 2022 Jul 19.
6
Identification of the Putative Tumor Suppressor Characteristics of FAM107A Pan-Cancer Analysis.FAM107A的假定肿瘤抑制特征鉴定 泛癌分析
Front Oncol. 2022 May 20;12:861281. doi: 10.3389/fonc.2022.861281. eCollection 2022.
7
Molecular Biological Comparison of Dental Pulp- and Apical Papilla-Derived Stem Cells.牙髓和根尖乳头来源的干细胞的分子生物学比较。
Int J Mol Sci. 2022 Feb 27;23(5):2615. doi: 10.3390/ijms23052615.
8
Identification of FAM107A as a potential biomarker and therapeutic target for prostate carcinoma.鉴定FAM107A作为前列腺癌的潜在生物标志物和治疗靶点。
Am J Transl Res. 2021 Sep 15;13(9):10163-10177. eCollection 2021.
9
Tumor mutation burden (TMB)-associated signature constructed to predict survival of lung squamous cell carcinoma patients.构建肿瘤突变负担(TMB)相关特征以预测肺鳞癌患者的生存情况。
Sci Rep. 2021 Apr 27;11(1):9020. doi: 10.1038/s41598-021-88694-7.
10
Construction of Decision Trees Based on Gene Expression Omnibus Data to Classify Bladder Cancer and Its Subtypes.基于基因表达综合数据库构建决策树以分类膀胱癌及其亚型。
Med Sci Monit. 2021 Mar 23;27:e929394. doi: 10.12659/MSM.929394.